Procurement Footprint
Astrazeneca — public-sector procurement footprint
From open OCDS records, AqlData resolved 292 name-spelling variants of Astrazeneca into one identity (88 legal entities) and mapped its public-sector footprint: 26 countries, ~$16.5B in awarded value, across 11,443+ tracked contracts (2002-05-24 – 2026-03-31).
26
countries
$16.5B
awarded value
11,443+
tracked contracts
1,314
public buyers
Geographic reach
| Country | Contracts | ~Value ($M) |
|---|---|---|
| IT | 1,820 | 5,212.6 |
| EU | 536 | 4,604.9 |
| GB | 53 | 2,161.3 |
| ES | 438 | 1,353.8 |
| SE | 42 | 818.7 |
| FI | 11 | 434.9 |
| + 20 more countries | in full report | — |
Top public buyers
| Buyer | Country | Contracts |
|---|---|---|
| Dirección General de la Salud | UY | 2,491 |
| Unidade Local de Saúde do Norte Alentejano, E. P. E. | PT | 334 |
| Instituto Português de Oncologia do Porto Francisco Ge | PT | 281 |
| + 1,311 more buyers — every agency, contract-level | — | in full report |
Activity over time
2015313
2016351
2017345
2018680
2019911
20201,092
2021850
20221,605
20231,370
20242,130
2025510
202627
The full due-diligence report
All 26 countries, every one of 1,314 public buyers at the contract level, single-customer revenue concentration, the top-5 buyer split and the buyer-level competitor map — the complete Astrazeneca due-diligence brief, delivered within 24 hours.
Request a worked sample